American Journal of Cardiology
Volume 104, Issue 6 , Pages 846-849 , 15 September 2009

Effect of Balloon Valvuloplasty in Patients With Severe Aortic Stenosis on Levels of N-Terminal Pro-B-Type Natriuretic Peptide

Received 1 March 2009 ,Revised 5 May 2009 ,Accepted 5 May 2009.

References 

  1. Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J. 2005;26:1023–1030
  2. Gerber IL, Stewart RAH, Legget ME, West TM, French RL, Sutton TM, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003;107:1884–1890
  3. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302–2308
  4. Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, et al. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis—one year follow-up. Eur J Heart Fail. 2006;8:257–262
  5. Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84–e231
  6. Webb JG, Pasupati S, Achtem L, Thomson CR. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv. 2006;68:199–204
  7. Klein A, Lee K, Gera A, Ports TA, Michaels AD. Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis. J Interv Cardiol. 2006;19:269–275
  8. Shareghi S, Rasouli L, Shavelle DM, Burstein S, Matthews RV. Current results of balloon aortic valvuloplasty in high-risk patients. J Invasive Cardiol. 2007;19:1–5
  9. Pedersen WR, Klaassen PJ, Boisjolie CR, Pierce TA, Harris KM, Lesser JR, et al. Feasibility of transcatheter intervention for severe aortic stenosis in patients ≥90 years of age: aortic valvuloplasty revisited. Catheter Cardiovasc Interv. 2007;70:149–154
  10. Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci. 1998;95:519–529
  11. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail. 2004;6:257–260
  12. Ikeda T, Matsuda K, Itoh H, Shirakami G, Miyamoto Y, Yoshimasa T, et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J. 1997;133:307–314
  13. Kupari M, Turto H, Lommi J, Mäkijärvi M, Parikka H. Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis. Eur J Heart Fail. 2005;7:809–814
  14. Bergler-Klein J, Mundigler G, Pibarot P, Burwash IG, Dumesnil JG, Blais C, et al. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis (Relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study). Circulation. 2007;115:2848–2855
  15. Hara H, Pedersen WR, Ladich E, Mooney M, Virmani R, Nakamura M, et al. Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance?. Circulation. 2007;115:334–338
  16. Descoutures F, Himbert D, Lepage L, Iung B, Détaint D, Tchetche D, et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J. 2008;29:1410–1417
  17. Lieberman EB, Wilson JS, Harrison JK, Pieper KS, Kisslo KB, Lowe J, et al. Aortic valve replacement in adults after balloon aortic valvuloplasty. Circulation. 1994;90:II205–II208
  18. Agarwal A, Kini A, Attanti S, Lee PC, Ashtiani R, Steinheimer AM, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol. 2005;95:43–47

PII: S0002-9149(09)01048-0

doi: 10.1016/j.amjcard.2009.05.013

American Journal of Cardiology
Volume 104, Issue 6 , Pages 846-849 , 15 September 2009